Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | VRM | Common Stock | Options Exercise | $105K | +25K | +50.19% | $4.21 | 74.8K | Jun 8, 2021 | Direct | |
transaction | VRM | Common Stock | Sale | -$1.08M | -25K | -33.42% | $43.38* | 49.8K | Jun 8, 2021 | Direct | F1, F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | VRM | Stock Option (Right to Buy) | Options Exercise | $0 | -25K | -11.11% | $0.00 | 200K | Jun 8, 2021 | Common Stock | 25K | $4.21 | Direct | F3 |
Id | Content |
---|---|
F1 | The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2020. |
F2 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.02 to $44.01. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
F3 | The option is vested and exercisable as to 200,000 shares, and the remaining shares vest and become exercisable in two equal annual installments beginning on November 12, 2021. |